1,924 reports of this reaction
2.2% of all OLANZAPINE PAMOATE reports
#3 most reported adverse reaction
DRUG INEFFECTIVE is the #3 most commonly reported adverse reaction for OLANZAPINE PAMOATE, manufactured by H2-Pharma LLC. There are 1,924 FDA adverse event reports linking OLANZAPINE PAMOATE to DRUG INEFFECTIVE. This represents approximately 2.2% of all 88,377 adverse event reports for this drug.
OLANZAPINE PAMOATE has an overall safety score of 85 out of 100. Patients taking OLANZAPINE PAMOATE who experience drug ineffective should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DRUG INEFFECTIVE is a less commonly reported adverse event for OLANZAPINE PAMOATE, but still significant enough to appear in the safety profile.
In addition to drug ineffective, the following adverse reactions have been reported for OLANZAPINE PAMOATE:
The following drugs have also been linked to drug ineffective in FDA adverse event reports:
DRUG INEFFECTIVE has been reported as an adverse event in 1,924 FDA reports for OLANZAPINE PAMOATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DRUG INEFFECTIVE accounts for approximately 2.2% of all adverse event reports for OLANZAPINE PAMOATE, making it one of the most commonly reported side effect.
If you experience drug ineffective while taking OLANZAPINE PAMOATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.